Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-09-017900
Filing Date
2009-03-31
Accepted
2009-03-31 16:36:05
Documents
14
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 v144351_10k.htm 10-K 2455369
2 GRAPHIC chart.jpg GRAPHIC 24649
3 ex10-26.htm EX-10.26 33226
4 ex10-27.htm EX-10.27 29687
5 ex10-28.htm EX-10.28 35457
6 ex10-29.htm EX-10.29 41609
7 ex10-30.htm EX-10.30 34624
8 ex10-31.htm EX-10.31 16383
9 ex10-32.htm EX-10.32 14397
10 ex10-33.htm EX-10.33 9099
11 v144351_ex21-1.htm EX-21.1 6384
12 ex31-1.htm EX-31.1 15159
13 ex31-2.htm EX-31.2 15082
14 ex32-1.htm EX-32.1 12437
  Complete submission text file 0001144204-09-017900.txt   2754543
Mailing Address NO. 6, YUANQUAN ROAD, WUQING NEW-TECH INDUSTRIAL PARK TIANJIN, P.R. F4 301700
Business Address NO. 6, YUANQUAN ROAD, WUQING NEW-TECH INDUSTRIAL PARK TIANJIN, P.R. F4 301700 86 22-82137264
TIENS BIOTECH GROUP USA INC (Filer) CIK: 0001168556 (see all company filings)

EIN.: 752926439
Type: 10-K | Act: 34 | File No.: 001-32477 | Film No.: 09719488
SIC: 2834 Pharmaceutical Preparations